| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 728206 | 98066020 | EXELON 4,6 mg/24 H PARCHE TRANSDERMICO | EXELON 4,6 mg/24 H PARCHE TRANSDERMICO, 30 parches | 4,6 mg/24 h | 74 | 30 | 28 | 30 parches | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98066020/98066020_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98066020/98066020_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2007-10-24 | 1 | 1 | 1 | 2007-10-24 | 2020-03-11 | 0 | 2020-12-10 | View Edit Delete | ||||||||||||
| 728207 | 98066020 | EXELON 4,6 mg/24 H PARCHE TRANSDERMICO | EXELON 4,6 mg/24 H PARCHE TRANSDERMICO, 60 (2 x 30) parches | 4,6 mg/24 h | 74 | 60 | 28 | 60 (2 x 30) parches | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98066020/98066020_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98066020/98066020_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2007-10-24 | 1 | 1 | 1 | 2007-10-24 | 2020-03-11 | 0 | 2020-12-10 | View Edit Delete | ||||||||||||
| 807420 | 98066013 | EXELON 2 mg/ml SOLUCION ORAL | EXELON 2 mg/ml SOLUCION ORAL, 1 frasco de 120 ml | 2 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98066013/98066013_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98066013/98066013_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 1999-11-01 | 1 | 1 | 1 | 1999-11-01 | 1999-11-01 | 1 | 2011-02-24 | View Edit Delete | ||||||||||||
| 659227 | 98066012 | EXELON 6 mg CAPSULAS DURAS | EXELON 6 mg CAPSULAS DURAS, 112 cápsulas | 6 mg | 5 | 112 | 43 | 112 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98066012/98066012_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98066012/98066012_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 1998-12-01 | 1 | 1 | 1 | 1998-12-01 | 1998-12-01 | 0 | 2011-02-24 | View Edit Delete | ||||||||||||
| 659235 | 98066011 | EXELON 6 mg CAPSULAS DURAS | EXELON 6 mg CAPSULAS DURAS, 56 cápsulas | 6 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98066011/98066011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98066011/98066011_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 1998-12-01 | 1 | 1 | 1 | 1998-12-01 | 1998-12-01 | 0 | 2011-02-24 | View Edit Delete | ||||||||||||
| 659250 | 98066009 | EXELON 4,5 mg CAPSULAS DURAS | EXELON 4,5 mg CAPSULAS DURAS, 112 cápsulas | 4,5 mg | 5 | 112 | 43 | 112 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98066009/98066009_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98066009/98066009_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 1998-12-01 | 1 | 1 | 1 | 1998-12-01 | 1998-12-01 | 0 | 2011-02-24 | View Edit Delete | ||||||||||||
| 659268 | 98066008 | EXELON 4,5 mg CAPSULAS DURAS | EXELON 4,5 mg CAPSULAS DURAS, 56 cápsulas | 4,5 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98066008/98066008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98066008/98066008_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 1998-12-01 | 1 | 1 | 1 | 1998-12-01 | 1998-12-01 | 0 | 2011-02-24 | View Edit Delete | ||||||||||||
| 659284 | 98066006 | EXELON 3 mg CAPSULAS DURAS | EXELON 3 mg CAPSULAS DURAS, 112 cápsulas | 3 mg | 5 | 112 | 43 | 112 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98066006/98066006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98066006/98066006_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 1998-12-01 | 1 | 1 | 1 | 1998-12-01 | 1998-12-01 | 0 | 2011-02-24 | View Edit Delete | ||||||||||||
| 659292 | 98066005 | EXELON 3 mg CAPSULAS DURAS | EXELON 3 mg CAPSULAS DURAS, 56 cápsulas | 3 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98066005/98066005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98066005/98066005_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 1998-12-01 | 1 | 1 | 1 | 1998-12-01 | 1998-12-01 | 0 | 2011-02-24 | View Edit Delete | ||||||||||||
| 659318 | 98066003 | EXELON 1,5 mg CAPSULAS DURAS | EXELON 1,5 mg CAPSULAS DURAS, 112 cápsulas | 1,5 mg | 5 | 112 | 43 | 112 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98066003/98066003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98066003/98066003_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 1998-12-01 | 1 | 1 | 1 | 1998-12-01 | 1998-12-01 | 0 | 2011-02-24 | View Edit Delete | ||||||||||||
| 659326 | 98066002 | EXELON 1,5 mg CAPSULAS DURAS | EXELON 1,5 mg CAPSULAS DURAS, 56 cápsulas | 1,5 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98066002/98066002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98066002/98066002_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 1998-12-01 | 1 | 1 | 1 | 1998-12-01 | 1998-12-01 | 0 | 2011-02-24 | View Edit Delete | ||||||||||||
| 659334 | 98066001 | EXELON 1,5 mg CAPSULAS DURAS | EXELON 1,5 mg CAPSULAS DURAS, 28 cápsulas | 1,5 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98066001/98066001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98066001/98066001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 1998-12-01 | 1 | 1 | 1 | 1998-12-01 | 1998-12-01 | 0 | 2011-02-24 | View Edit Delete | ||||||||||||
| 661033 | 98065002 | OPTISON SUSPENSION INYECTABLE | OPTISON SUSPENSION INYECTABLE, 5 viales de 3 ml | 0,19 mg/ml inyectable 3 ml | 45 | 5 | 34 | 5 viales de 3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98065002/98065002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98065002/98065002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7727 | GE HEALTHCARE BIO SCIENCES S.A. | 1998-07-01 | 1 | 1 | 1 | 1998-07-01 | 1998-07-01 | 1 | 2015-11-17 | View Edit Delete | ||||||||||||
| 729313 | 98063009IP | REBIF 44 microgramos/0,5 ml SOLUCION INYECTABLE EN CARTUCHO | REBIF 44 microgramos/0,5 ml SOLUCION INYECTABLE EN CARTUCHO, 4 cartuchos de 1,5 ml | 44 microgramos | 33 | 4 | 57 | 4 cartuchos de 1,5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98063009IP/98063009IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98063009IP/98063009IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29251 | ABACUS MEDICINE A/S | 2020-10-01 | 1 | 1 | 1 | 2020-10-02 | 2020-10-01 | 1 | 2021-01-19 | View Edit Delete | ||||||||||||
| 662219 | 98063009 | REBIF 44 MICROGRAMOS/0,5 ML SOLUCION INYECTABLE EN CARTUCHO | REBIF 44 MICROGRAMOS/0,5 ML SOLUCION INYECTABLE EN CARTUCHO , 4 cartuchos de 1,5 ml | 44 microgramos | 33 | 4 | 57 | 4 cartuchos de 1,5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98063009/98063009_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98063009/98063009_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29251 | MERCK S.L. | 2009-02-04 | 1 | 1 | 1 | 2009-02-04 | 2009-02-04 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 662218 | 98063008 | REBIF 22 MICROGRAMOS/0,5 ML SOLUCION INYECTABLE EN CARTUCHO | REBIF 22 MICROGRAMOS/0,5 ML SOLUCION INYECTABLE EN CARTUCHO , 4 cartuchos de 1,5 ml | 22 microgramos | 33 | 4 | 57 | 4 cartuchos de 1,5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98063008/98063008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98063008/98063008_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29251 | MERCK S.L. | 2009-02-04 | 1 | 1 | 1 | 2009-02-04 | 2009-02-04 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 661587 | 98058001 | COMBIVIR 150 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | COMBIVIR 150 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 60 comprimidos | 150 mg/300 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98058001/98058001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98058001/98058001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 34670 | LABORATORIOS VIIV HEALTHCARE S.L. | 1998-11-01 | 1 | 1 | 1 | 1998-11-01 | 1998-11-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 661231 | 98057001 | QUADRAMET, SOLUCION INYECTABLE | QUADRAMET, SOLUCION INYECTABLE, 1 vial de 15 ml | 1,3 GBq/ml | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98057001/98057001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98057001/98057001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 689 | CURIUM PHARMA SPAIN S.A. | 1998-09-01 | 1 | 1 | 1 | 1998-09-01 | 1998-09-01 | 0 | 2012-01-09 | View Edit Delete | ||||||||||||
| 807404 | 97055002 | VIRAMUNE 50 mg/5 ml SUSPENSION ORAL | VIRAMUNE 50 mg/5 ml SUSPENSION ORAL, 1 frasco de 240 ml | 10 mg/ml | 6 | 240 | 26 | 1 frasco de 240 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/97055002/97055002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/97055002/97055002_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5126 | BOEHRINGER INGELHEIM ESPANA S.A. | 2000-06-27 | 1 | 1 | 1 | 2000-06-27 | 2000-06-27 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 864058 | 97053003 | CEREZYME 400 UNIDADES POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | CEREZYME 400 UNIDADES POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 5 ml | 400 U | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/97053003/97053003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/97053003/97053003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 42448 | SANOFI AVENTIS S.A. | 2000-05-30 | 1 | 1 | 1 | 2000-05-30 | 2000-05-30 | 1 | 2011-09-06 | View Edit Delete |
Page 28 of 1036, showing 20 records out of 20715 total, starting on record 541, ending on 560